Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Fever in the returning traveller

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Any unwell traveller from a malaria-risk area needs urgent malaria testing, even if prophylaxis was taken. Isolate and contact infection and health-protection specialists immediately for bleeding, unexplained shock, severe respiratory illness or epidemiology compatible with a high-consequence infectious disease.

Synopsis

Assess fever after international travel by stabilising first, excluding malaria immediately, reconstructing exposure and incubation, applying isolation early and selecting targeted microbiology before empirical treatment.

  • Ask exactly where and when the patient travelled, including stopovers, urban versus rural setting, dates, season and illness onset; incubation time removes many impossible diagnoses.
  • Malaria is the first exclusion after travel to a risk area because falciparum disease can deteriorate rapidly and prophylaxis does not provide complete protection.
  • Take a precise exposure history: mosquitoes and ticks, fresh water, animals, food and water, sexual contact, healthcare, caves, funerals, mass gatherings and sick contacts.
  • Use early isolation for possible airborne or high-consequence infection before an exhaustive interview; protect staff while urgent clinical care continues.
  • Look for syndrome patterns—rash, jaundice, diarrhoea, eosinophilia, cytopenias, hepatosplenomegaly, neurological change and respiratory failure—without treating any single clue as diagnostic.
  • Discuss unusual samples and empirical treatment with infection or microbiology specialists; malaria films, cultures and molecular tests have timing and handling requirements.
  • Notify suspected notifiable disease on clinical suspicion and coordinate contacts or post-exposure action through the local health-protection team.

Key red flags

Possible falciparum malaria

Fever with rigors, headache, cytopenia, jaundice, confusion, acidosis or renal injury after malaria-area travel is an emergency even without a regular fever pattern.

Enteric fever pattern

Sustained fever, abdominal symptoms, relative bradycardia, hepatosplenomegaly or travel with unsafe food and water raises typhoid or paratyphoid disease.

Arboviral pattern

Acute fever with rash, severe myalgia, arthralgia, retro-orbital pain, leucopenia or thrombocytopenia suggests dengue, chikungunya or another vector-borne virus according to geography.

High-consequence signal

Bleeding, unexplained shock, severe respiratory syndrome or exposure to outbreaks, healthcare, caves, animals or funerals requires immediate isolation and specialist risk assessment.

Investigation priorities

01
Urgent malaria blood films and rapid diagnostic testingFirst step

Detect malaria species, parasitaemia and features requiring severe-disease management.

Management branches

Travel from malaria regionExclude malaria immediately

Any current or recent fever follows travel to an area with malaria transmission.

  1. Perform ABCDE, check glucose and travel dates, take urgent malaria films and rapid testing and request infection or tropical-medicine advice.
  2. Assess severity including consciousness, lactate or acidosis, renal function, jaundice, anaemia, respiratory compromise and parasitaemia; admit and treat promptly when severe or falciparum malaria is possible.
  3. Repeat testing when advised if the first result is negative and suspicion remains, while investigating other imported and ordinary infections in parallel.
Stable undifferentiated feverUse incubation and exposure to focus tests

The traveller is physiologically stable and immediate malaria and high-consequence pathways have been addressed.

  1. Construct a country-by-date timeline and map food, water, vector, animal, freshwater, sexual, healthcare and medicine exposures against illness onset.
  2. Examine for rash, nodes, jaundice, organomegaly, murmur, focal chest, abdominal or neurological signs and obtain targeted cultures and laboratory tests.
  3. Review results with infection specialists, give syndrome-directed treatment when supported and provide explicit deterioration and pending-result follow-up.

Key medicines

Intravenous artesunateGive 2.4 mg/kg intravenously at 0, 12 and 24 hours, then every 24 hours until oral treatment is tolerated; after at least three doses, complete a full specialist-selected oral combination course.Do not delay for transfer or perfect species confirmation when severe malaria is likely. Monitor glucose, parasitaemia and organ failure; arrange full blood count and haemolysis surveillance after discharge because delayed artesunate-associated haemolysis can emerge over the following 4 weeks.
Atovaquone with proguanilFor adults over 40 kg with selected uncomplicated falciparum malaria, give four 250/100 mg tablets orally once daily for three days with food.Not for severe malaria. Give with food, repeat a dose vomited within 1 hour, and seek an alternative after repeated vomiting. Review severe renal impairment, pregnancy and anticoagulant monitoring, avoid reusing a failed prophylactic drug, and confirm species-specific follow-up with the specialist service.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UK malaria diagnosis and treatment guidelinesNational malaria testing, severity and treatment recommendations.
  • UKHSA high consequence infectious diseasesCurrent definitions and specialist operational pathways.
  • UKHSA notifiable disease reportingNotification and health-protection action for imported infections.
  • NHS Fit for TravelNHS travel-risk, malaria and destination information used to reconstruct exposure.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom